Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production
- PMID: 16084736
- DOI: 10.1016/j.biologicals.2005.05.003
Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production
Abstract
The rabies vaccine is produced by inactivation of rabies virus propagated on BHK21 cells. In the rabies inactivation process, BEI is added at a final concentration of 1.6 mM to the viral harvest at 37 degrees C, followed by a second dose of BEI at 24 h post-inactivation. Inactivation was confirmed by the mice innocuity test and tissue culture amplification test as per B.P (Vet) 2004. Validation of test procedure is essential as per cGMP requirement. The dose of BEI was validated by using lower and higher concentrations of BEI in inactivation process. The study indicated that BEI at a lower concentration (0.4 mM) was able to inactivate the rabies virus within 30 h and the routine concentration (1.6 mM) of BEI is effective in inactivating rabies virus within 18 h. The amplification test used for confirming the inactivation of the live virus was validated by spiking the sample with different dilutions of pretitrated live rabies virus. The test revealed that the amplification method is sensitive to detect live rabies virus if present in the inactivated sample. The validation of BEI as an inactivant and the amplification test are discussed.
Similar articles
-
Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.Biologicals. 2004 Sep;32(3):153-6. doi: 10.1016/j.biologicals.2004.09.001. Biologicals. 2004. PMID: 15536046
-
Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production.J Clin Microbiol. 1980 Feb;11(2):120-2. doi: 10.1128/jcm.11.2.120-122.1980. J Clin Microbiol. 1980. PMID: 7358836 Free PMC article.
-
Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.Res Vet Sci. 2008 Dec;85(3):589-94. doi: 10.1016/j.rvsc.2007.12.009. Epub 2008 Feb 8. Res Vet Sci. 2008. PMID: 18262212
-
Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.Vaccine. 1990 Aug;8(4):299-303. doi: 10.1016/0264-410x(90)90083-x. Vaccine. 1990. PMID: 2204242 Free PMC article. Review.
-
Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.Expert Rev Vaccines. 2009 May;8(5):607-18. doi: 10.1586/erv.09.19. Expert Rev Vaccines. 2009. PMID: 19397417 Review.
Cited by
-
Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.Clin Exp Vaccine Res. 2021 May;10(2):141-147. doi: 10.7774/cevr.2021.10.2.141. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222126 Free PMC article.
-
The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.Vet World. 2019 Jun;12(6):758-764. doi: 10.14202/vetworld.2019.758-764. Epub 2019 Jun 8. Vet World. 2019. PMID: 31439989 Free PMC article.
-
Preparation of an Inactivated Peste des Petits Ruminants Vaccine and Its Comparative Immunogenicity Evaluation in an Animal Model.Arch Razi Inst. 2021 Oct 31;76(4):731-739. doi: 10.22092/ari.2020.351398.1523. eCollection 2021 Oct. Arch Razi Inst. 2021. PMID: 35096309 Free PMC article.
-
Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.J Vet Med Sci. 2018 Nov 1;80(10):1596-1603. doi: 10.1292/jvms.17-0385. Epub 2018 Sep 11. J Vet Med Sci. 2018. PMID: 30210066 Free PMC article.
-
Efficacy of inactivated velogenic Newcastle disease virus genotype VII vaccine in broiler chickens.Vet Res Forum. 2020 Spring;11(2):113-120. doi: 10.30466/vrf.2019.95311.2295. Epub 2020 Jun 15. Vet Res Forum. 2020. PMID: 32782739 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources